Patients with HR+/HER2− metastatic breast cancer without previous systemic therapy were randomly assigned to receive either ...

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have ...

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

In addition to using gemcitabine and the natural killer cells that are TGF-β imprinted, we also are combining an anti-GD2 antibody called naxitamab that's provided by Y-mAbs. Naxitamab, as I said, is ...

Mentor, mother, activist, advocate, sister, survivor, researcher and Fred Hutch friend, Bridgette Hempstead died last month ...

ABC 6 News is continuing the series "Inside the Fight of Breast Cancer" with part four surrounding breast cancer prevention.

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

After her fight with breast cancer, an area high school girls basketball coach wanted to find a way to help others in their ...

Countryfile veteran Julia Bradbury was on the verge of tears discussing her harrowing breast cancer journey. As a prominent ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...